When a ‘Miracle’ Cystic Fibrosis Drug Is Out of Reach

Trikafta’s U.S. list price is over $322,000 a year. That is nearly 60 times the annual salary of a minimum wage earner in Turkey, where the government wanted to import a generic version made in Argentina. Vertex sued and blocked it.

Vertex has brought in $17 billion from Trikafta since 2019. An analysis by researchers in Britain found that a year’s supply of the drug could be manufactured for just $5,700.

The company says it is working to increase access to the drug globally.

#Miracle #Cystic #Fibrosis #Drug #Reach

Leave a Comment